Deep vein thrombosis (DVT) is a common health problem and can lead to significant morbidity and even mortality when unsuccessfully treated. The incidence of DVT in the United States is estmiated at up to 550000 cases per year. In spite of the need for a model to effectively evaluate new therapeutic devices, there is no consistent preclinical model of DVT. Absorption Systems, Inc. (ASI), has developed a unique and consistent model which enables the evaluation of experimental intravascular thrombectomy devices. The model allows for the evaluation of devices in different sized vessels (both length and diameter) as well as thombus maturity. This model can fill the need for medical device companies who have so far been unable to perform consistent preclinical trials during device development. Prez Marek, Study Director, Absorption Systems, Inc. Innovation Video Briefs